Loading...

Analysts Raise Entegris Price Target as Earnings Guidance Spurs Modest Valuation Adjustment

Published
21 Aug 24
Updated
23 Oct 25
AnalystConsensusTarget's Fair Value
US$101.08
9.5% undervalued intrinsic discount
23 Oct
US$91.52
Loading
1Y
-12.8%
7D
0.6%

Author's Valuation

US$101.089.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on23 Oct 25
Fair value Increased 0.33%

Analysts have modestly increased their price target for Entegris from $100.75 to $101.08. This reflects minor adjustments based on updated fair value estimates and forecast refinements.

Shared on08 Oct 25
Fair value Increased 1.77%

Narrative Update on Entegris: Analyst Price Target Revision Analysts have slightly increased their price target for Entegris from $99.00 to $100.75, reflecting modest adjustments in key financial assumptions and updated forecasts. What's in the News Entegris issued earnings guidance for the third quarter ending September 27, 2025, and projects sales between $780 million and $820 million (Key Developments).

Shared on07 May 25
Fair value Decreased 14%

Shared on30 Apr 25
Fair value Decreased 1.93%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 4.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 3.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.078%

AnalystConsensusTarget has decreased profit margin from 21.4% to 16.5% and increased future PE multiple from 29.6x to 38.4x.

Shared on10 Mar 25
Fair value Increased 29%

AnalystConsensusTarget has decreased revenue growth from 8.8% to 7.3% and decreased future PE multiple from 38.8x to 29.6x.